Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CB1 inverse agonist 1 (MRL-650) is an orally active and selective CB1 agonist. The IC50s for CB1 and CB2 are 7.5 nM and 4100 nM, respectively. CB1 inverse agonist 1 shows anorexigenic effects.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 195.00 | |
5 mg | In stock | $ 447.00 | |
10 mg | In stock | $ 659.00 | |
25 mg | In stock | $ 987.00 | |
50 mg | In stock | $ 1,380.00 | |
100 mg | In stock | $ 1,890.00 | |
500 mg | In stock | $ 3,790.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 547.00 |
Description | CB1 inverse agonist 1 (MRL-650) is an orally active and selective CB1 agonist. The IC50s for CB1 and CB2 are 7.5 nM and 4100 nM, respectively. CB1 inverse agonist 1 shows anorexigenic effects. |
Targets&IC50 | CB2:4100 nM, CB1:7.5 nM |
In vivo | CB1 inverse agonist 1 (0.3-3 mg/kg) dose-dependently inhibits feeding in a manner[1]. |
Synonyms | MRL-650 |
Molecular Weight | 514.79 |
Formula | C25H18Cl3N3O3 |
CAS No. | 852315-00-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (87.41 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CB1 inverse agonist 1 852315-00-5 GPCR/G Protein Cannabinoid Receptor MRL 650 MRL-650 MRL650 inhibitor inhibit